0001093557-22-000016.txt : 20220214
0001093557-22-000016.hdr.sgml : 20220214
20220214170606
ACCESSION NUMBER: 0001093557-22-000016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220210
FILED AS OF DATE: 20220214
DATE AS OF CHANGE: 20220214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAHN BARBARA
CENTRAL INDEX KEY: 0001520391
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 22634417
MAIL ADDRESS:
STREET 1: C/O DEXCOM, INC.
STREET 2: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-02-10
0
0001093557
DEXCOM INC
DXCM
0001520391
KAHN BARBARA
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2022-02-10
4
S
0
100
428.55
D
7566
I
by Trust
Common Stock
2022-02-10
4
S
0
100
430.06
D
7466
I
by Trust
Common Stock
2022-02-10
4
S
0
100
435.64
D
7366
I
by Trust
Common Stock
2022-02-10
4
S
0
100
438.21
D
7266
I
by Trust
Common Stock
2022-02-10
4
S
0
200
440.845
D
7066
I
by Trust
Common Stock
2022-02-10
4
S
0
476
442.1825
D
6590
I
by Trust
Common Stock
2022-02-10
4
S
0
1147
434.355
D
5443
I
by Trust
Common Stock
2022-02-10
4
S
0
443
443.562
D
5000
I
by Trust
Common Stock
2022-02-10
4
S
0
400
444.8
D
4600
I
by Trust
Common Stock
2022-02-10
4
S
0
200
445.845
D
4400
I
by Trust
Common Stock
2022-02-10
4
S
0
200
447.35
D
4200
I
by Trust
Common Stock
2022-02-10
4
S
0
400
448.975
D
3800
I
by Trust
Common Stock
2022-02-10
4
S
0
200
450.065
D
3600
I
by Trust
Common Stock
2022-02-10
4
S
0
200
451.285
D
3400
I
by Trust
Common Stock
2022-02-10
4
S
0
400
452.495
D
3000
I
by Trust
Common Stock
918
D
On November 12, 2021, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.
Represents 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.
This transaction was executed in multiple trades at prices ranging from $440.65 to $441.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
his transaction was executed in multiple trades at prices ranging from $441.69 to $442.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $434.28 to $434.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $442.93 to $443.89. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $444.35 to $445.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
his transaction was executed in multiple trades at prices ranging from $445.54 to $446.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $447.06 to $447.64. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $448.53 to $449.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $449.61 to $450.52. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $450.96 to $451.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $451.96 to $452.94. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
By: Jereme Sylvain For: Barbara E Kahn
2022-02-14